VITAIRA is acquiring Hommel Pharma GmbH & Co. KG to jointly drive the development of a European temperature-controlled specialty logistics group for pharmaceutical and healthcare services—ranging from GDP-compliant transportation and warehousing solutions to GMP-certified value-added services.
The demands on the pharmaceutical supply chain in Europe are increasing: Regulatory requirements are growing, supply chains are becoming more complex, and expectations regarding transparency and supply security are rising. At the same time, demographic change is leading to rising demand for pharmaceutical products and related services. Efficient, integrated logistics structures are therefore becoming increasingly important.
VITAIRA is investing in a European specialty logistics group specializing in temperature-controlled transport
VITAIRA’s objective is to acquire complementary logistics and transportation companies. Hommel Pharma is a key component in strategically expanding this network and strengthening coverage in core European markets. By leveraging network synergies, the combined service portfolio is strengthened, enabling growth with both existing and new customers.
Specialized logistics and fulfillment expertise from Dülmen
Hommel Pharma Logistik is a specialized service provider offering logistics and fulfillment solutions for the pharmaceutical and healthcare industries, based in Dülmen. The company handles key tasks throughout the value chain—from storage and order fulfillment to the shipment of pharmaceuticals and medical products, as well as products from the Consumer Health portfolio, including temperature-controlled processes.
Focus of the Partnership: Standards, Scalability, and Digital Interoperability
The collaboration focuses on the further development of a high-performance, compliance-oriented platform for pharmaceutical and healthcare clients. This includes, in particular:
- standardized quality and compliance processes for temperature-controlled supply chains (GDP/GMP-compliant),
- scalable service and fulfillment structures for sophisticated healthcare value creation (including value-added services),
- Digital process integration and transparency to enhance traceability and controllability throughout the supply chain.
Comments on the Partnership
“With Hommel Pharma, we are gaining a partner that consistently approaches pharmaceutical and healthcare services from the perspective of regulated supply chains. The Dülmen location strengthens our presence in the D-A-CH region while also creating a strategic link to the Benelux countries—an important step in building our European temperature-controlled specialty logistics group.” – Andreas Thiede, CEO & Founder of VITAIRA
“As a pharmaceutical and healthcare service provider, our mission is to reliably support customers in complex, regulated process chains—and to continuously improve our services. With VITAIRA, we combine clear standards and digital transparency with a European growth outlook.” – Thomas Möbus, Managing Director of Hommel Pharma
About VITAIRA
VITAIRA was founded in August 2025 and is building a European network of specialized pharmaceutical and transportation logistics companies through the acquisition of complementary logistics and transportation firms. The goal is to consolidate temperature-controlled pharmaceutical and healthcare services along regulated supply chains on a single platform. The CEO and founder is Andreas Thiede.
About Hommel Pharma
Hommel Pharma GmbH & Co. KG is a pharmaceutical and healthcare service provider headquartered in Dülmen. The company supports customers in the healthcare market with logistics and fulfillment services across regulated supply chains and combines standardized processes with digital process integration and transparency throughout the order and service chain.